Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trial.

Porter, Joanna C; Inshaw, Jamie; Solis, Vincente Joel; Denneny, Emma; Evans, Rebecca; Temkin, Mia I; De Vasconcelos, Nathalia; Aramburu, Iker Valle; Hoving, Dennis; Basire, Donna; +15 more... Crissell, Tracey; Guinto, Jesusa; Webb, Alison; Esmail, Hanif; Johnston, Victoria; Last, Anna; Rampling, Thomas; Lippert, Lena; Helbig, Elisa Theresa; Kurth, Florian; Williams, Bryan; Flynn, Aiden; Lukey, Pauline T; Birault, Veronique; Papayannopoulos, Venizelos; (2024) Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trial. eLife, 12. RP87030-. ISSN 2050-084X DOI: https://doi.org/10.7554/eLife.87030

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.7554/eLife.87030

Abstract

Share

Download

Filename: Porter-etal-2024-Anti-inflammatory-therapy-with-nebulized-dornase-alfa-for-severe-covid-19-pneumonia.pdf

Licence: Creative Commons: Attribution 4.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar